SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vidadi Yusibov, Natasha Kushnir, Stephen J Streatfield, Advances and challenges in the development and production of effective plant-based influenza vaccines, Expert Review of Vaccines, 2015, 14, 4, 519

    CrossRef

  2. 2
    Florian Krammer, Peter Palese, Advances in the development of influenza virus vaccines, Nature Reviews Drug Discovery, 2015, 14, 3, 167

    CrossRef

  3. 3
    François Le Mauff, Geneviève Mercier, Philippe Chan, Carole Burel, David Vaudry, Muriel Bardor, Louis-Philippe Vézina, Manon Couture, Patrice Lerouge, Nathalie Landry, Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants, Plant Biotechnology Journal, 2015, 13, 2
  4. 4
    Yoko Shoji, Alex Prokhnevsky, Brett Leffet, Nancy Vetter, Stephen Tottey, Shama Satinover, Konstantin Musiychuk, Moneim Shamloul, Joey Norikane, R Mark Jones, Jessica A Chichester, Brian J Green, Stephen J Streatfield, Vidadi Yusibov, Immunogenicity of H1N1 influenza virus-like particles produced inNicotiana benthamiana, Human Vaccines & Immunotherapeutics, 2015, 11, 1, 118

    CrossRef

  5. 5
    Goeun Lee, Yun Jeong Na, Bo-Gie Yang, Jun-Pyo Choi, Yong Bok Seo, Chun-Pyo Hong, Chang Ho Yun, Dae Heon Kim, Eun Ju Sohn, Jeong Hee Kim, Young Chul Sung, Yoon-Keun Kim, Myoung Ho Jang, Inhwan Hwang, Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection, Plant Biotechnology Journal, 2015, 13, 1
  6. 6
    Julia Transfiguracion, Aziza P. Manceur, Emma Petiot, Christine M. Thompson, Amine A. Kamen, Particle quantification of influenza viruses by high performance liquid chromatography, Vaccine, 2015, 33, 1, 78

    CrossRef

  7. 7
    Shah Fahad, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Muhammad Mahmood Ahmed, Yu Cai Liao, Muhammad Tahir Waheed, Muhammad Sameeullah, Darkhshan, Saddam Hussain, Shah Saud, Shah Hassan, Amanullah Jan, Mohammad Tariq Jan, Chao Wu, Ma Xiao Chun, Jianliang Huang, Recent developments in therapeutic protein expression technologies in plants, Biotechnology Letters, 2015, 37, 2, 265

    CrossRef

  8. 8
    Slavica Matić, Emanuela Noris, Applied Plant Genomics and Biotechnology, 2015,

    CrossRef

  9. 9
    Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo, Anton P.J. Middelberg, Bioengineering virus-like particles as vaccines, Biotechnology and Bioengineering, 2014, 111, 3
  10. 10
    Jae Yong Yoo, Ki Seong Ko, Sang Yeol Lee, Kyun Oh Lee, Glycoengineering in plants for the development of N-glycan structures compatible with biopharmaceuticals, Plant Biotechnology Reports, 2014, 8, 5, 357

    CrossRef

  11. 11
    Nathalie Landry, Stéphane Pillet, David Favre, Jean-François Poulin, Sonia Trépanier, Bader Yassine-Diab, Brian J. Ward, Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens, Clinical Immunology, 2014, 154, 2, 164

    CrossRef

  12. 12
    Kathleen Hefferon, Plant Virus Expression Vector Development: New Perspectives, BioMed Research International, 2014, 2014, 1

    CrossRef

  13. 13
    Edward P Rybicki, Plant-based vaccines against viruses, Virology Journal, 2014, 11, 1, 205

    CrossRef

  14. 14
    James F. Cummings, Melanie L. Guerrero, James E. Moon, Paige Waterman, Robin K. Nielsen, Stacie Jefferson, F. Liaini Gross, Kathy Hancock, Jacqueline M. Katz, Vidadi Yusibov, Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults, Vaccine, 2014, 32, 19, 2251

    CrossRef

  15. 15
    Jyothi K Mallajosyula, Ernie Hiatt, Steve Hume, Ashley Johnson, Trushar Jeevan, Rachel Chikwamba, Gregory P Pogue, Barry Bratcher, Hugh Haydon, Richard J Webby, Alison A McCormick, Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge, Human Vaccines & Immunotherapeutics, 2014, 10, 3, 586

    CrossRef

  16. 16
    Agnieszka Rynda-Apple, Dustin P Patterson, Trevor Douglas, Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung, Nanomedicine, 2014, 9, 12, 1857

    CrossRef

  17. 17
    Yoko Shoji, R. Mark Jones, Vadim Mett, Jessica A. Chichester, Konstantin Musiychuk, Xiangjie Sun, Terrence M. Tumpey, Brian J. Green, Moneim Shamloul, Joey Norikane, Hong Bi, Caitlin E. Hartman, Cory Bottone, Michelle Stewart, Stephen J. Streatfield, Vidadi Yusibov, A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge, Human Vaccines & Immunotherapeutics, 2013, 9, 3, 553

    CrossRef

  18. 18
    Christine M Thompson, Emma Petiot, Alexandre Lennaertz, Olivier Henry, Amine A Kamen, Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches, Virology Journal, 2013, 10, 1, 141

    CrossRef

  19. 19
    Hoang T. Phan, Julia Pohl, Doreen M. Floss, Frank Rabenstein, Jutta Veits, Binh T. Le, Ha H. Chu, Gerd Hause, Thomas Mettenleiter, Udo Conrad, ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice, Plant Biotechnology Journal, 2013, 11, 5
  20. 20
    Alaina J Mooney, S Mark Tompkins, Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses, Future Virology, 2013, 8, 1, 25

    CrossRef

  21. 21
    Mariana Baz, Catherine J. Luke, Xing Cheng, Hong Jin, Kanta Subbarao, H5N1 vaccines in humans, Virus Research, 2013, 178, 1, 78

    CrossRef

  22. 22
    SAMANTHA K. WATSON, JAMES W. RUDGE, RICHARD COKER, Health Systems’ “Surge Capacity”: State of the Art and Priorities for Future Research, Milbank Quarterly, 2013, 91, 1
  23. 23
    Shih-Chang Lin, Wen-Chun Liu, Yu-Fen Lin, Yu-Hsuan Huang, Jin-Hwang Liu, Suh-Chin Wu, Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses, Biotechnology Journal, 2013, 8, 11
  24. 24
    Qiang Chen, Huafang Lai, Plant-derived virus-like particles as vaccines, Human Vaccines & Immunotherapeutics, 2013, 9, 1, 26

    CrossRef

  25. 25
    Ma-ping Deng, Zhi-hong Hu, Hua-lin Wang, Fei Deng, Developments of subunit and VLP vaccines against influenza a virus, Virologica Sinica, 2012, 27, 3, 145

    CrossRef

  26. 26
    Selvaraju Kanagarajan, Saraladevi Muthusamy, Anna Gliszczyńska, Anneli Lundgren, Peter E. Brodelius, Functional expression and characterization of sesquiterpene synthases from Artemisia annua L. using transient expression system in Nicotiana benthamiana, Plant Cell Reports, 2012, 31, 7, 1309

    CrossRef

  27. 27
    Rainer Fischer, Stefan Schillberg, Stephan Hellwig, Richard M. Twyman, Juergen Drossard, GMP issues for recombinant plant-derived pharmaceutical proteins, Biotechnology Advances, 2012, 30, 2, 434

    CrossRef

  28. 28
    Giampaolo Buriani, Camillo Mancini, Eugenio Benvenuto, Selene Baschieri, Heat-shock protein 70 from plant biofactories of recombinant antigens activate multiepitope-targeted immune responses, Plant Biotechnology Journal, 2012, 10, 3
  29. 29
    Philip Dormitzer, Theodore Tsai, Giuseppe Del Giudice, New technologies for influenza vaccines, Human Vaccines & Immunotherapeutics, 2012, 8, 1, 45

    CrossRef

  30. 30
    Edward P. Rybicki, Rachel Chikwamba, Muffy Koch, James I. Rhodes, Jan-Hendrik Groenewald, Plant-made therapeutics: An emerging platform in South Africa, Biotechnology Advances, 2012, 30, 2, 449

    CrossRef

  31. 31
    N. V. Ravin, R. Y. Kotlyarov, E. S. Mardanova, V. V. Kuprianov, A. I. Migunov, L. A. Stepanova, L. M. Tsybalova, O. I. Kiselev, K. G. Skryabin, Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein, Biochemistry (Moscow), 2012, 77, 1, 33

    CrossRef

  32. 32
    Falko Schmeisser, Joan E. Adamo, Benjamin Blumberg, Rachel Friedman, Jacqueline Muller, Jackeline Soto, Jerry P. Weir, Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase, Vaccine, 2012, 30, 23, 3413

    CrossRef

  33. 33
    Jessica Chichester, R. Jones, Brian Green, Mark Stow, Fudu Miao, George Moonsammy, Stephen Streatfield, Vidadi Yusibov, Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults, Viruses, 2012, 4, 12, 3227

    CrossRef

  34. 34
    Åsne Jul-Larsen, Abdullah S. Madhun, Karl A. Brokstad, Emanuele Montomoli, Vidadi Yusibov, Rebecca J. Cox, The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants, Human Vaccines & Immunotherapeutics, 2012, 8, 5, 653

    CrossRef

  35. 35
    Qi Chen, Darin Madson, Cathy L. Miller, D.L. Hank Harris, Vaccine development for protecting swine against influenza virus, Animal Health Research Reviews, 2012, 13, 02, 181

    CrossRef

  36. 36
    Natasha Kushnir, Stephen J. Streatfield, Vidadi Yusibov, Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development, Vaccine, 2012, 31, 1, 58

    CrossRef

  37. 37
    David R. Thomas, Claire A. Penney, Amrita Majumder, Amanda M. Walmsley, Evolution of Plant-Made Pharmaceuticals, International Journal of Molecular Sciences, 2011, 12, 12, 3220

    CrossRef

  38. 38
    Claire A. Penney, David R. Thomas, Sadia S. Deen, Amanda M. Walmsley, Plant-made vaccines in support of the Millennium Development Goals, Plant Cell Reports, 2011, 30, 5, 789

    CrossRef

  39. 39
    Rajesh Arora, R. Chawla, Rohit Marwah, P. Arora, R. K. Sharma, Vinod Kaushik, R. Goel, A. Kaur, M. Silambarasan, R. P. Tripathi, J. R. Bhardwaj, Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud, Evidence-Based Complementary and Alternative Medicine, 2011, 2011, 1

    CrossRef

  40. 40
    Assunta Pelosi, Claire Penney, Huai-Yian Ling, Amanda M Walmsley, Plant-derived Vaccines: Technologies & Applications, 2011,

    CrossRef

  41. 41
    What's New About Crop Plants, 2011,

    CrossRef

  42. 42
    Chiara Lico, Giampaolo Buriani, Floriana Capuano, Eugenio Benvenuto, Selene Baschieri, Plant-derived Vaccines: Technologies & Applications, 2011,

    CrossRef

  43. 43
    Charles Goulet, Catherine Goulet, Marie-Claire Goulet, Dominique Michaud, 2-DE proteome maps for the leaf apoplast of Nicotiana benthamiana, PROTEOMICS, 2010, 10, 13
  44. 44
    Huai-Yian Ling, Assunta Pelosi, Amanda M Walmsley, Current status of plant-made vaccines for veterinary purposes, Expert Review of Vaccines, 2010, 9, 8, 971

    CrossRef

  45. 45
    Florian Krammer, Theresa Schinko, Paul Messner, Dieter Palmberger, Boris Ferko, Reingard Grabherr, Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis, Journal of Virological Methods, 2010, 167, 1, 17

    CrossRef

  46. 46
    Matthew Paul, Julian K-C Ma, Plant-made immunogens and effective delivery strategies, Expert Review of Vaccines, 2010, 9, 8, 821

    CrossRef

  47. 47
    Edward P. Rybicki, Plant-made vaccines for humans and animals, Plant Biotechnology Journal, 2010, 8, 5
  48. 48
    Véronique Gomord, Anne-Catherine Fitchette, Laurence Menu-Bouaouiche, Claude Saint-Jore-Dupas, Carole Plasson, Dominique Michaud, Loïc Faye, Plant-specific glycosylation patterns in the context of therapeutic protein production, Plant Biotechnology Journal, 2010, 8, 5
  49. 49
    Iain Stephenson, Frederick Hayden, Albert Osterhaus, Wendy Howard, Yuri Pervikov, Laszlo Palkonyay, Marie-Paule Kieny, Report of the fourth meeting on ‘Influenza vaccines that induce broad spectrum and long-lasting immune responses’, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009, Vaccine, 2010, 28, 23, 3875

    CrossRef

  50. 50
    Yun-Kiam Yap, Duncan R. Smith, Strategies for the plant-based expression of dengue subunit vaccines, Biotechnology and Applied Biochemistry, 2010, 57, 2
  51. 51
    Florian Krammer, Sabine Nakowitsch, Paul Messner, Dieter Palmberger, Boris Ferko, Reingard Grabherr, Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice, Biotechnology Journal, 2010, 5, 1
  52. 52
    Marc-André D’Aoust, Manon M.-J. Couture, Nathalie Charland, Sonia Trépanier, Nathalie Landry, Frédéric Ors, Louis-P. Vézina, The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza, Plant Biotechnology Journal, 2010, 8, 5
  53. 53
    Tatiana V Komarova, Selene Baschieri, Marcello Donini, Carla Marusic, Eugenio Benvenuto, Yuri L Dorokhov, Transient expression systems for plant-derived biopharmaceuticals, Expert Review of Vaccines, 2010, 9, 8, 859

    CrossRef

  54. 54
    Florian Krammer, Theresa Schinko, Dieter Palmberger, Christopher Tauer, Paul Messner, Reingard Grabherr, Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines, Molecular Biotechnology, 2010, 45, 3, 226

    CrossRef

  55. 55
    António Roldão, Maria Candida M Mellado, Leda R Castilho, Manuel JT Carrondo, Paula M Alves, Virus-like particles in vaccine development, Expert Review of Vaccines, 2010, 9, 10, 1149

    CrossRef

  56. 56
    Biotech paper watch, Biotechnology Journal, 2009, 4, 1
  57. 57
    Sang-Moo Kang, Jae-Min Song, Fu-Shi Quan, Richard W. Compans, Influenza vaccines based on virus-like particles, Virus Research, 2009, 143, 2, 140

    CrossRef

  58. 58
    Joel R Haynes, Influenza virus-like particle vaccines, Expert Review of Vaccines, 2009, 8, 4, 435

    CrossRef

  59. 59
    Henry Daniell, Nameirakpam D. Singh, Hugh Mason, Stephen J. Streatfield, Plant-made vaccine antigens and biopharmaceuticals, Trends in Plant Science, 2009, 14, 12, 669

    CrossRef

  60. 60
    Ruth Arnon, Tamar Ben-Yedidia, Preclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1, Future Microbiology, 2009, 4, 5, 503

    CrossRef

  61. 61
    Jessica A Chichester, Lars R Haaheim, Vidadi Yusibov, Using plant cells as influenza vaccine substrates, Expert Review of Vaccines, 2009, 8, 4, 493

    CrossRef

  62. 62
    Klaus Stöhr, Influenza vaccine production,
  63. 63
    Yap Pang Chuan, Linda H. L. Lua, Anton P. J. Middelberg, Virus-Like Particle Bioprocessing,